Syros Pharmaceuticals Investor Relations Material
Latest events
Q3 2024
Syros Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Syros Pharmaceuticals Inc
Access all reports
Syros Pharmaceuticals Inc. is a biopharmaceutical company focused on developing targeted therapies for cancer and other serious diseases. The company uses its proprietary gene control platform to identify and develop small-molecule drugs that modulate the expression of specific genes associated with disease. Syros's pipeline includes investigational treatments for hematologic cancers, solid tumors, and other genetically defined diseases. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
SYRS
Country
🇺🇸 United States